Evidence map›Paper›PMID 34587750›Full record

Trial reportCirculation2021

Epigenetic Age and the Risk of Incident Atrial Fibrillation.

Jason D Roberts, Eric Vittinghoff, Ake T Lu, Alvaro Alonso, Biqi Wang, Colleen M Sitlani, Pedrum Mohammadi-Shemirani, Myriam Fornage, Jelena Kornej, Jennifer A Brody and 18 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Circulation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Accelerated epigenetic age in hypertension: a systematic review and meta-analysis.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Pooled it
  2. Guideline
  3. Guideline
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Jason D RobertsPopulation Health Research Institute (J.D.R., P.M-S., G.P.).ORCID 0000-0003-0268-6723
Eric VittinghoffDepartment of Epidemiology and Biostatistics (E.V.) University of California, San Francisco.ORCID 0000-0001-8535-0920
Ake T LuDepartment of Human Genetics, David Geffen School of Medicine (A.T.L., S.H.); University of California, Los Angeles.ORCID 0000-0002-2866-7961
Alvaro AlonsoDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA (A.A.).ORCID 0000-0002-2225-8323
Biqi WangFramingham Heart Study, Framingham, MA (B.W., J.K., H.L., E.J.B.).
Colleen M SitlaniCardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).ORCID 0000-0001-7656-7482
Pedrum Mohammadi-ShemiraniPopulation Health Research Institute (J.D.R., P.M-S., G.P.).
Myriam FornageBrown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston (M.F.).ORCID 0000-0003-0677-8158
Jelena KornejFramingham Heart Study, Framingham, MA (B.W., J.K., H.L., E.J.B.).ORCID 0000-0003-3551-1145
Jennifer A BrodyCardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).ORCID 0000-0001-8509-148X
Dan E ArkingMcKusick-Nathans Institute, Department of Genetic Medicine, Baltimore, MD (D.E.A.).ORCID 0000-0001-8980-8695
Honghuang LinFramingham Heart Study, Framingham, MA (B.W., J.K., H.L., E.J.B.).ORCID 0000-0003-3043-3942
Susan R HeckbertCardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).ORCID 0000-0002-7100-512X
Ivana ProkicDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands (I.P., M.G.).ORCID 0000-0002-0370-1473
Mohsen GhanbariDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands (I.P., M.G.).ORCID 0000-0002-9476-7143
Allan C SkanesSection of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, ON, Canada (J.D.R., A.C.S.).
Traci M BartzCardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).
Marco V PerezDivision of Cardiovascular Medicine, Stanford University School of Medicine, CA (M.V.P.).ORCID 0000-0003-2746-0202
Kent D TaylorInstitute for Translational Genomics, The Lundquist Institute at Harbour-University of California, Los Angeles Medical Center, Torrance, CA (K.D.T.).ORCID 0000-0002-2756-4370
Steven A LubitzCardiovascular Research Center (S.A.L., P.T.E.); Massachusetts General Hospital, Boston.ORCID 0000-0002-9599-4866
Patrick T EllinorCardiovascular Research Center (S.A.L., P.T.E.); Massachusetts General Hospital, Boston.ORCID 0000-0002-2067-0533
Kathryn L LunettaDepartments of Biostatistics (B.W., K.L.L.), School of Public Health.ORCID 0000-0002-9268-810X
James S PankowDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (J.S.P.).ORCID 0000-0001-7076-483X
Guillaume ParéPopulation Health Research Institute (J.D.R., P.M-S., G.P.).ORCID 0000-0002-6795-4760
Nona SotoodehniaCardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).
Emelia J BenjaminFramingham Heart Study, Framingham, MA (B.W., J.K., H.L., E.J.B.).ORCID 0000-0003-4076-2336
Steve HorvathDepartment of Biostatistics, School of Public Health (S.H.); University of California, Los Angeles.
Gregory M MarcusSection of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine (G.M.M.); University of California, San Francisco.ORCID 0000-0001-5197-7696

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MILES Frome WILKINSON · 2003 to 2026
$40.4M
FRAMINGHAM HEART STUDY - YEAR 5 EXAM75N92019D00031 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · 2019 to 2024
$29.8M
Building on GWAS for NHLBI-disease: the CHARGE consortiumRC2HL102419 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2009 to 2010
$27.6M
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
Utilizing the Phenomics of IBD to Enhance Gene DiscoveryU01DK062413 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Dermot Patrick McGovern · 2002 to 2026
$12.2M
Exceptional Survival: Trajectories to Functional Aging (CHS All Stars)R01AG023629 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NEWMAN, ANNE B. · 2004 to 2016
$9.5M
CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
Rare variants and NHLBI traits in deeply phenotyped cohortsR01HL120393 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, RICE, KENNETH M. · 2014 to 2016
$8.9M
CHS research resources for the cardiovascular health of older adultsU01HL130114 · NHLBI · UNIVERSITY OF WASHINGTON · PI BURKE, GREGORY L, KRONMAL, RICHARD A · 2016 to 2019
$6.6M
Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortiumR01HL103612 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2011 to 2014
$5.4M
American Heart Association-American Stroke Association 16EIA26410001NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR001881NHLBI NIH HHS 75N92019D00031NHLBI NIH HHS HHSN268200800007CNHLBI NIH HHS HHSN268201200036CNHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS HHSN268201700001CNHLBI NIH HHS HHSN268201700001INHLBI NIH HHS HHSN268201700002CNHLBI NIH HHS HHSN268201700002INHLBI NIH HHS HHSN268201700003CNHLBI NIH HHS HHSN268201700003INHLBI NIH HHS HHSN268201700004CNHLBI NIH HHS HHSN268201700004INHLBI NIH HHS HHSN268201700005CNHLBI NIH HHS HHSN268201700005INHLBI NIH HHS HHSN268201800001CNHLBI NIH HHS K08 HL116640NHLBI NIH HHS K24 HL148521NHLBI NIH HHS N01 HC055222NHLBI NIH HHS N01 HC085079NHLBI NIH HHS N01 HC085080NHLBI NIH HHS N01 HC085081NHLBI NIH HHS N01 HC085082NHLBI NIH HHS N01 HC085083NHLBI NIH HHS N01 HC085086NHLBI NIH HHS R01 HL087652NHLBI NIH HHS R01 HL092111NHLBI NIH HHS R01 HL092577NHLBI NIH HHS R01 HL103612NHLBI NIH HHS R01 HL105756NHLBI NIH HHS R01 HL111089NHLBI NIH HHS R01 HL116747NHLBI NIH HHS R01 HL120393NHLBI NIH HHS R01 HL128914NHLBI NIH HHS R01 HL139731NHLBI NIH HHS R01 HL141989NHLBI NIH HHS RC2 HL102419NHLBI NIH HHS U01 HL080295NHLBI NIH HHS U01 HL130114NIA NIH HHS R01 AG023629NIA NIH HHS U01 AG060908NIDDK NIH HHS P30 DK063491NIDDK NIH HHS U01 DK062413NINDS NIH HHS R01 NS087541
6 · The paper itself

Abstract

backgroundThe most prominent risk factor for atrial fibrillation (AF) is chronological age; however, underlying mechanisms are unexplained. Algorithms using epigenetic modifications to the human genome effectively predict chronological age. Chronological and epigenetic predicted ages may diverge in a phenomenon referred to as epigenetic age acceleration (EAA), which may reflect accelerated biological aging. We sought to evaluate for associations between epigenetic age measures and incident AF.

methodsMeasures for 4 epigenetic clocks (Horvath, Hannum, DNA methylation [DNAm] PhenoAge, and DNAm GrimAge) and an epigenetic predictor of PAI-1 (plasminogen activator inhibitor-1) levels (ie, DNAm PAI-1) were determined for study participants from 3 population-based cohort studies. Cox models evaluated for associations with incident AF and results were combined via random-effects meta-analyses. Two-sample summary-level Mendelian randomization analyses evaluated for associations between genetic instruments of the EAA measures and AF.

resultsAmong 5600 participants (mean age, 65.5 years; female, 60.1%; Black, 50.7%), there were 905 incident AF cases during a mean follow-up of 12.9 years. Unadjusted analyses revealed all 4 epigenetic clocks and the DNAm PAI-1 predictor were associated with statistically significant higher hazards of incident AF, though the magnitudes of their point estimates were smaller relative to the associations observed for chronological age. The pooled EAA estimates for each epigenetic measure, with the exception of Horvath EAA, were associated with incident AF in models adjusted for chronological age, race, sex, and smoking variables. After multivariable adjustment for additional known AF risk factors that could also potentially function as mediators, pooled EAA measures for 2 clocks remained statistically significant. Five-year increases in EAA measures for DNAm GrimAge and DNAm PhenoAge were associated with 19% (adjusted hazard ratio [HR], 1.19 [95% CI, 1.09-1.31];

conclusionsOur study identified adjusted associations between EAA measures and incident AF, suggesting that biological aging plays an important role independent of chronological age, though a potential underlying causal relationship remains unclear. These aging processes may be modifiable and not constrained by the immutable factor of time.

Indexed as

AgingDNA MethylationEpigenesis, GeneticModels, CardiovascularModels, GeneticAgedAtrial FibrillationEpigenomicsFemaleFollow-Up StudiesHumansIncidenceMaleMendelian Randomization AnalysisMiddle Agedagingatrial fibrillationepigenomicsgenetics

Identifiers

PMID34587750
PMCPMC8671333

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.